TERBINAFINE HCL 5%- terbinafine hcl 5% solution 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

TERBINAFINE HCL 5%

Directions for use

qwe

Sincerus Florida, LLC. Adverse reactions

ad

Active, inactive

swf

NDC 72934- 4175-9 TERBINAFINE HCL USP 5%. Solution 15 gm

d

TERBINAFINE HCL 5% 
terbinafine hcl 5% solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-4175
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TERBINAFINE HYDROCHLORIDE (UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP) TERBINAFINE HYDROCHLORIDE5 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-4175-915 g in 1 VIAL; Type 0: Not a Combination Product05/21/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/21/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-4175)

Revised: 5/2019
Document Id: 8966ec7b-dd57-1a48-e053-2a95a90a13b4
Set id: 8966ec7b-dd56-1a48-e053-2a95a90a13b4
Version: 1
Effective Time: 20190521
 
Sincerus Florida, LLC